Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AI FAME is a Swiss private company focused on the breeding, cultivation, harvesting, processing, and commercialization of cannabis plants for food and medical use. The company appears to operate a GMP-certified facility in Wald-Schönengrund, St. Gallen, and has positioned itself as a producer of pharmaceutical-quality cannabis-derived active ingredients and extracts. Publicly available sources indicate that its product portfolio has included cannabinoid APIs such as tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, cannabidiolic acid, and cannabichromene, as well as hemp-flower extract. AI FAME has also been described as conducting plant research and development around cannabis genetics and desired compound profiles. The company looks to be a commercial-stage supplier rather than a clinical-stage therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AI FAME.